Labsystems Diagnostics Oy is based in Finland and has been a forerunner in innovative diagnostic research and development for nearly 40 years, pioneering new technologies for newborn screening and point of care testing. Labsystems is dedicated to high quality enzyme immunoassays (EIA and FEIA) and rapid point of care tests for professional and home use. Labsystems Diagnostics Oy develops and manufactures complete neonatal screening systems, infectious disease and gastrointestinal tests. These top quality Finnish made products are sold globally through group sales units as well as through strategic partners’ sales and distribution networks. Labsystems Diagnostics was the first to: - Develop fluorometric PKU [Phenylketonuria] tests for NBS - Provide PKU assays in micro-plate format We continue to invest in our R&D and are strongly committed to developing innovative newborn diagnostics solutions at our state of the art production facility in Vantaa, Finland. Our objective is to deliver products fulfilling our quality criteria in agreed time and ensure the patient safety and the customer satisfaction at all times. To achieve our goals, the whole personnel is conscious about the importance of the high quality.